APPLICATION
ANDA208860
TYPE
ANDA
ORIGINAL APPROVAL
2017-11-06
LATEST ACTION
2023-01-09
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
CLOFARABINEDiscontinued
CLOFARABINE 20MG/20ML (1MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2023-01-09Labeling · Supplement 7 · standardAP
2021-05-19Labeling · Supplement 2 · standardAP
2017-11-06UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.